Not applicableLooking for participantsNCT06547710What this trial is testingPrimary Tumor Resection for M1a Stage Lung CancerWho this might be right forLung Cancer MetastaticSurgical Resection Fudan University 66
Testing effectiveness (Phase 2)Looking for participantsNCT06822543What this trial is testingA Single Arm, Phase 2 Study of Datopotamab Deruxtecan, Carboplatin, and Pembrolizumab for Treatment-naive Brain Metastases From NSCLC (Non-small Cell Lung Cancer)Who this might be right forLung CancerNon Small Cell Lung CancerBrain Metastases Latin American Cooperative Oncology Group 46
Testing effectiveness (Phase 2)Looking for participantsNCT07685938What this trial is testingPharmacologic Therapies to Mitigate Radiation- Associated Heart DiseaseWho this might be right forChest Wall TumorBreast CancerLung Cancer+6 more UNC Lineberger Comprehensive Cancer Center 60
Testing effectiveness (Phase 2)WithdrawnNCT02672358What this trial is testingStudy of Efficacy and Safety of Dabrafenib and Trametinib Combination Therapy in Japanese Patients With BRAF V600E Stage IV NSCLCWho this might be right forNon-Small-Cell Lung Cancer Novartis Pharmaceuticals
Early research (Phase 1)Looking for participantsNCT04913285What this trial is testingEvaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid TumorsWho this might be right forSolid Tumor, AdultNon-small Cell Lung CancerMelanoma Pierre Fabre Medicament 400
Early research (Phase 1)UnknownNCT05942508What this trial is testingA Phase Ib Study of TQB2450 Combined With Anlotinib in Patients With Limited Stage Small Cell Lung Cancer After First-line Radiotherapy and ChemotherapyWho this might be right forLimited Stage Small Cell Lung CancerNot Progressed After First-line Chemoradiotherapy Jinming Yu 20
Testing effectiveness (Phase 2)Ended earlyNCT01870609What this trial is testingPlacebo Controlled Study of VS-6063 in Subjects With Malignant Pleural MesotheliomaWho this might be right forMalignant Pleural Mesothelioma Verastem, Inc. 344
Testing effectiveness (Phase 2)Looking for participantsNCT07371663What this trial is testingAn Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid TumorsWho this might be right forSolid CancersNSCLC (Advanced Non-small Cell Lung Cancer)Gastric (Stomach) Cancer+2 more Beijing Tide Pharmaceutical Co., Ltd 266
Early research (Phase 1)Study completedNCT00884598What this trial is testingCilengitide and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases From Lung CancerWho this might be right forBrain and Central Nervous System TumorsLung Cancer Universitätsmedizin Mannheim 19
Large-scale testing (Phase 3)Ended earlyNCT00876915What this trial is testingDalteparin Prophylaxis in High-Risk Ambulatory Cancer PatientsWho this might be right forVenous ThromboembolismPulmonary Embolism University of Rochester 218
Testing effectiveness (Phase 2)Study completedNCT03213678What this trial is testingSamotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial)Who this might be right forAdvanced Malignant Solid NeoplasmAnn Arbor Stage III Non-Hodgkin LymphomaAnn Arbor Stage IV Non-Hodgkin Lymphoma+30 more National Cancer Institute (NCI) 18
Early research (Phase 1)Active Not RecruitingNCT03333343What this trial is testingStudy of EGF816 in Combination With Selected Targeted Agents in EGFR-mutant NSCLCWho this might be right forEGFR-mutant Non-small Cell Lung Cancer Novartis Pharmaceuticals 105
Large-scale testing (Phase 3)UnknownNCT02281708What this trial is testingMulticenter Randomized Controlled Trial Adjuvant Chemotherapy vs Observation in pStage Ib Lung AdenocarcinomaWho this might be right forStage Ib Lung Carcinoma Seoul National University Hospital 1,012
Testing effectiveness (Phase 2)Looking for participantsNCT04991025What this trial is testingAdding Certolizumab to Chemotherapy + Nivolumab in People Who Have Lung Cancer That Can Be Treated With SurgeryWho this might be right forLung CancerLung Cancer Stage IILung Cancer Stage III Memorial Sloan Kettering Cancer Center 60
Post-approval studies (Phase 4)Study completedNCT05997225What this trial is testingTobacco Cessation at FDNYWho this might be right forTobacco UseTobacco SmokingTobacco Use Cessation Albert Einstein College of Medicine 23
Not applicableLooking for participantsNCT07768124What this trial is testingAcupoint Application for Chemotherapy-Induced Nausea and Vomiting in Lung CancerWho this might be right forLung Cancer (Diagnosis)Chemotherapy-Induced Nausea and Vomiting Xiu Huang 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06971406What this trial is testingHigh-Dose Firmonertinib Combined With Bevacizumab and Intrathecal Pemetrexed in the Treatment of EGFR-Mutated Non-Small Cell Lung Cancer With Leptomeningeal MetastasisWho this might be right forNon Small Cell Lung CancerEGFR MutationLeptomeningeal Metastases+1 more Qiming Wang 100
Early research (Phase 1)Ended earlyNCT03509584What this trial is testingPhase I Multicenter Trial Combining Nivolumab, Ipilimumab and Hypo-fractionated Radiotherapy for Pretreated Advanced Stage Non-small Cell Lung Cancer PatientsWho this might be right forNon-small Cell Lung Cancer Assistance Publique Hopitaux De Marseille 6
Early research (Phase 1)Active Not RecruitingNCT06544655What this trial is testingBMS-986484 Alone and Combination Therapy in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors Bristol-Myers Squibb 213
Not applicableWithdrawnNCT04917224What this trial is testingStudy of LUNG Stereotactic Adaptive Ablative RadiotherapyWho this might be right forLung CancerLung Tumor Baptist Health South Florida